Cargando…
Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles
A potent cell division cycle 7 (CDC7) kinase inhibitor, known as PHA-767491, has been described to reduce the transactive response DNA binding protein of 43 KDa (TDP-43) phosphorylation in vitro and in vivo, which is one of the main proteins found to aggregate and accumulate in the cytoplasm of moto...
Autores principales: | Rojas-Prats, Elisa, Tosat-Bitrián, Carlota, Martínez-González, Loreto, Nozal, Vanesa, Pérez, Daniel I., Martínez, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912371/ https://www.ncbi.nlm.nih.gov/pubmed/33525757 http://dx.doi.org/10.3390/pharmaceutics13020180 |
Ejemplares similares
-
Cell division cycle 7-kinase inhibitor PHA-767491 hydrochloride suppresses glioblastoma growth and invasiveness
por: Erbayraktar, Zubeyde, et al.
Publicado: (2016) -
TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patients
por: Martinez-Gonzalez, Loreto, et al.
Publicado: (2023) -
Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo
por: Hou, Jue, et al.
Publicado: (2017) -
From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein‐Templated Synthesis
por: Nozal, Vanesa, et al.
Publicado: (2021) -
Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML
por: O’ Reilly, Eimear, et al.
Publicado: (2018)